124 related articles for article (PubMed ID: 9120809)
1. Controlled release of thyrotropin releasing hormone from microspheres: evaluation of release profiles and pharmacokinetics after subcutaneous administration.
Heya T; Mikura Y; Nagai A; Miura Y; Futo T; Tomida Y; Shimizu H; Toguchi H
J Pharm Sci; 1994 Jun; 83(6):798-801. PubMed ID: 9120809
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo evaluation of thyrotrophin releasing hormone release from copoly(dl-lactic/glycolic acid) microspheres.
Heya T; Okada H; Ogawa Y; Toguchi H
J Pharm Sci; 1994 May; 83(5):636-40. PubMed ID: 8071811
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist.
Du L; Cheng J; Chi Q; Qie J; Liu Y; Mei X
Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1259-65. PubMed ID: 16946531
[TBL] [Abstract][Full Text] [Related]
4. Application of a spray drying technique in the production of TRH-containing injectable sustained-release microparticles of biodegradable polymers.
Takada S; Uda Y; Toguchi H; Ogawa Y
PDA J Pharm Sci Technol; 1995; 49(4):180-4. PubMed ID: 7552237
[TBL] [Abstract][Full Text] [Related]
5. Utilization of an amorphous form of a water-soluble GPIIb/IIIa antagonist for controlled release from biodegradable microspheres.
Takada S; Kurokawa T; Miyazaki K; Iwasa S; Ogawa Y
Pharm Res; 1997 Sep; 14(9):1146-50. PubMed ID: 9327440
[TBL] [Abstract][Full Text] [Related]
6. [Design and development of controlled release of drugs from injectable microcapsules].
Takada S; Ogawa Y
Nihon Rinsho; 1998 Mar; 56(3):675-9. PubMed ID: 9549355
[TBL] [Abstract][Full Text] [Related]
7. Microencapsulation of luteinizing hormone-releasing hormone agonist in poly (lactic-co-glycolic acid) microspheres by spray-drying.
Shi NQ; Zhou J; Walker J; Li L; Hong JKY; Olsen KF; Tang J; Ackermann R; Wang Y; Qin B; Schwendeman A; Schwendeman SP
J Control Release; 2020 May; 321():756-772. PubMed ID: 31935481
[TBL] [Abstract][Full Text] [Related]
8. Prolonged anti-inflammatory action of DL-lactide/glycolide copolymer nanospheres containing betamethasone sodium phosphate for an intra-articular delivery system in antigen-induced arthritic rabbit.
Horisawa E; Hirota T; Kawazoe S; Yamada J; Yamamoto H; Takeuchi H; Kawashima Y
Pharm Res; 2002 Apr; 19(4):403-10. PubMed ID: 12033371
[TBL] [Abstract][Full Text] [Related]
9. The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) (PLGA) microspheres.
Cleland JL; Mac A; Boyd B; Yang J; Duenas ET; Yeung D; Brooks D; Hsu C; Chu H; Mukku V; Jones AJ
Pharm Res; 1997 Apr; 14(4):420-5. PubMed ID: 9144725
[TBL] [Abstract][Full Text] [Related]
10. Preparation of glucagon-like peptide-1 loaded PLGA microspheres: characterizations, release studies and bioactivities in vitro/in vivo.
Yin D; Lu Y; Zhang H; Zhang G; Zou H; Sun D; Zhong Y
Chem Pharm Bull (Tokyo); 2008 Feb; 56(2):156-61. PubMed ID: 18239299
[TBL] [Abstract][Full Text] [Related]
11. Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers.
Okada H; Doken Y; Ogawa Y; Toguchi H
Pharm Res; 1994 Aug; 11(8):1143-7. PubMed ID: 7971715
[TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation in vitro and vivo of copoly (lactic/glycolic) acid microspheres containing norethisterone.
Zhou Z; Zhou M; Wang S; Lin F; Shan W
Biomater Artif Cells Immobilization Biotechnol; 1993; 21(1):71-84. PubMed ID: 8461438
[TBL] [Abstract][Full Text] [Related]
13. Design and development of a novel controlled release PLGA alginate-pectinate polyspheric drug delivery system.
Sweet JL; Pillay V; Choonara YE
Drug Deliv; 2007 Jul; 14(5):309-18. PubMed ID: 17613019
[TBL] [Abstract][Full Text] [Related]
14. Biodegradable polymeric microspheres for nalbuphine prodrug controlled delivery: in vitro characterization and in vivo pharmacokinetic studies.
Liu FI; Kuo JH; Sung KC; Hu OY
Int J Pharm; 2003 May; 257(1-2):23-31. PubMed ID: 12711158
[TBL] [Abstract][Full Text] [Related]
15. Controlled release of nalbuphine propionate from biodegradable microspheres: in vitro and in vivo studies.
Yen SY; Sung KC; Wang JJ; Yoa-Pu Hu O
Int J Pharm; 2001 Jun; 220(1-2):91-9. PubMed ID: 11376971
[TBL] [Abstract][Full Text] [Related]
16. Particle size studies for subcutaneous delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation.
Uchida T; Goto S; Foster TP
J Pharm Pharmacol; 1995 Jul; 47(7):556-60. PubMed ID: 8568620
[TBL] [Abstract][Full Text] [Related]
17. Validation of a cage implant system for assessing in vivo performance of long-acting release microspheres.
Doty AC; Hirota K; Olsen KF; Sakamoto N; Ackermann R; Feng MR; Wang Y; Choi S; Qu W; Schwendeman A; Schwendeman SP
Biomaterials; 2016 Dec; 109():88-96. PubMed ID: 27693924
[TBL] [Abstract][Full Text] [Related]
18. Comparison of in vitro and in vivo release characteristics of sustained release ofloxacin microspheres.
Abazinge M; Jackson T; Yang Q; Owusu-Ababio G
Drug Deliv; 2000; 7(2):77-81. PubMed ID: 10892407
[TBL] [Abstract][Full Text] [Related]
19. The release profiles and bioactivity of parathyroid hormone from poly(lactic-co-glycolic acid) microspheres.
Wei G; Pettway GJ; McCauley LK; Ma PX
Biomaterials; 2004 Jan; 25(2):345-52. PubMed ID: 14585722
[TBL] [Abstract][Full Text] [Related]
20. High bioavailabilty of alpha-tocopherol loaded into poly (DL-lactic-co-glycolic acid) microspheres in apolipoprotein B knockout mice.
Yokogawa K; Shima Y; Hashimoto T; Hiyajyo M; Kadoyama K; Ishizaki J; Nomura M; Miyamoto K
Pharm Res; 2003 Nov; 20(11):1846-50. PubMed ID: 14661931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
